Navigation Links
In Health Science IT, ‘Scan’ is the New Four-letter Word
Date:12/30/2013

Rancho Cordova, California (PRWEB) December 30, 2013

Health science companies are becoming increasingly concerned with the exorbitant labor costs and quality issues created by document scanning and related manual paper-based processes. As companies learn more about the cost of digitizing paper documents, Scan is becoming the industry’s new four-letter word.    

To help BioPharma companies quantify the true cost of manual paper-based processes, such as scanning, tagging, and paper archiving, SureClinical announced today that it’s making available 'Estimating Trial Master File Costs,' a new white paper. Besides this free report, SureClinical is also offering its health science cloud-consulting service to help companies evaluate, design, and implement collaborative cloud computing solutions for content management.

As health science companies increasingly move from paper to electronic systems, many important regulatory documents, contracts, and workflows still utilize wet ink signatures on hardcopy documents. Hardcopy paper documents are sent by overnight delivery for signature, shipped back overnight, manually scanned and tagged, and then archived in electronic document management systems. Companies that thought moving from paper to electronic systems would save money are increasingly finding that significant costs are involved in scanning, tagging, and processing paper.

When health science companies signed up to “go electronic” to eliminate paper by digitizing paper documents, many of them didn’t realize the significant investment in labor, software, and scanning equipment that would be required. Digitizing documents is an extremely labor-intensive process that typically requires human labor to review, classify, and tag documents. Just one error during the scanning and tagging process can result in lost documents and quality issues that can impact many related business processes.

Instead of hurling four-letter invectives over the increased cost due to scanning and digitizing paper, organizations in healthcare and BioPharma are looking to replace scanning with cloud digital signing and cloud collaboration technologies. Cloud digital signing technologies enable electronic document completion and capture at the point of document origination, eliminating the need for costly scanning processes and accelerating document completion.

For example, in the clinical trials area, a new standards initiative called the Electronic Trial Master File Standard aims to provide support for cloud-based digital signing of documents as well as support for cloud-based document exchange and collaboration.

In healthcare, a new standard and system known as the Electronic Submission of Medical Documentation System (EsMD) eliminates the need for mailing paper medical bill authorizations and costly scanning and tagging in the US Medicare program. By using digital signing along with a secure cloud system that links healthcare providers with payors, the new EsMD initiative will eliminate the need for costly document scanning, reduce manual coding and tagging, and also reduce the number of fraudulent documents.

SureClinical, a start-up firm in the health science applications area, is one of the first companies to offer health science application solutions that use a secure collaborative cloud approach to content management. SureClinical’s Certified Cloud includes integrated document completion and signing and archiving for networks of health science organizations that wish to share documents in an automated, yet regulated cloud environment.

About SureClinical

Headquartered in Northern California, SureClinical is the premier provider of health science content management software applications for BioPharma. SureClinical’s mobile health science content management solutions run on Android®, Apple® iPad, Apple® IOS, and other popular smartphone platforms, as well as on all major web browsers. For more information, visit http://www.SureClinical.com.

Copyright © 2013 SureClinical. All rights reserved. SureClinical, SureEsign, SureTrial, Certified Cloud, and the SureTrial logo are trademarks of SureClinical. Other names used herein may be trademarks of their respective owners.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11453891.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Parma Community General Hospital and EMH Healthcare will become part of University Hospitals effective January 1, 2014
2. Tele-Medicine and M-health (PTT) Push to Talk Device Market 2019 Forecast and Analysis in Research Report
3. Pharma Pricing and Market Access News from HealthEconomics.Com for December 20, 2013
4. Sigma-Aldrich Corporation To Present At 32nd Annual J.P. Morgan Healthcare Conference
5. New 2 Hour Educational Learning Labs at MD&M West Will Feature Baxter Bioscience, BMW, Dell, GE Healthcare, Mattel, Northrup Grumman, Starbucks and Other Leading Groups in Design, Manufacturing, Engineering and Automation
6. HealthEconomics.Com Launches Live Streaming Educational Series in HE-Xpo®, the Pharma Industry’s Only Online Virtual Community for Health Economics and Outcomes Research
7. Dr. Ira Williams Invited To IHI 25th National Forum On Quality Improvement In Health Care
8. Obama Administration Issues New Rounds Of Cancer Care Cuts Amidst Healthcare Reform Chaos
9. Intrexon Strengthens Leadership in Companys Rapidly Growing Health Sector
10. Health R&D spending moves slowly upward, driven by industry, philanthropy and voluntary associations
11. CNTS Awarded $40 Million Contract Supporting U.S. Military Through Global Public Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)...  Personal Genome Diagnostics Inc. (PGDx) today announced ... the U.S. Department of Veterans Affairs (VA) that ... company,s new CancerSELECT ™ 125 test. CancerSELECT ... test that includes microsatellite instability status (MSI), a ... checkpoint inhibitor immunotherapies. CancerSELECT 125 will be available ...
(Date:3/20/2017)... CA (PRWEB) , ... March ... ... are substances that interfere with the ability of endogenous hormones to regulate ... inhibiting ligand binding activity (antagonists), EDCs produce adverse reproductive, neurological, proliferative, and ...
(Date:3/20/2017)... ... March 20, 2017 , ... Charm Sciences, ... & play system that counts Peel Plate microbial test colonies, stores plate images, ... stand-alone unit has an internal computer, and is accurate within 10% of an ...
(Date:3/20/2017)... , March 20, 2017 Western Institutional Review ... ethical review of clinical research, announced today the launch ... (SRS) for NIH-funded multi-site research. As the ... institution clients, WIRB has an extensive background in reviewing ... status as the IRB of record for the majority ...
Breaking Biology Technology:
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
Breaking Biology News(10 mins):